
AN EFFICACY COMPARISON STUDY BETWEEN TOPICAL ANTI ALLERGIC DRUGS IN PATIENTS WITH ALLERGIC CONJUNCTIVITIS IN WESTERN RAJASTHAN
Author(s) -
Pushpendra Chotiya,
Arvind Chauhan
Publication year - 2020
Publication title -
paripex indian journal of research
Language(s) - English
DOI - 10.36106/paripex/9204998
Subject(s) - allergic conjunctivitis , medicine , dermatology , clinical efficacy , incidence (geometry) , allergy , surgery , immunology , physics , optics
Backgroud : Allergic conjunctivitis is disturbing condition for patients and challenging condition for treating ophthalmologist and with increasing environmental pollution, the incidence of allergic conjunctivitis is increasing . Severe disease requires steroid but milder form can be treated with newer topical anti allergic medication (combined anti‑histaminic and mast cell stabilization function).Aim: In this study we compare efficacy of olopatadine (0.2%), bepotastine (1.5%), and alcaftadine (0.25%) in treatment of allergic conjunctivitis .Methods: In this randomized, double blind clinical trial 60 allergic conjunctivitis patients divided in three groups. Relief of symptoms and signs were noted and compared.Results: There was no statistical significant difference found in terms of efficacy of all three drugs in resolving symptoms of allergic conjunctivitis, .There is almost complete relief after 1 week of use of medication ( P < 0.001).